Reclassifying HFmrEF as a stable phenotype aims to reduce therapeutic inertia and GDMT underuse driven by heterogeneous ...
Functional assessment and classification in heart failure encompass a spectrum of tools and frameworks designed to quantify a patient’s symptoms, exercise capacity and underlying cardiac performance.
The heart failure (HF) treatment landscape continues to evolve rapidly in 2026, with emerging evidence pointing toward a ...
Cardiosense, a healthcare technology company focused on heart failure care, today announced that the U.S. Food & Drug Administration (FDA) has granted De Novo classification for its PCWP Analysis ...
BNP levels are sensitive to such other biological factors as age, gender, sex, weight, and renal function. BNP levels may be elevated in cases of acute MI, pulmonary embolism, and chronic obstructive ...
Heart failure is when the heart does not pump enough blood around the body. Biventricular heart failure is when chambers on both sides of the heart, known as ventricles, are affected. Doctors classify ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results